ECBK
ECB Bancorp, Inc.
ECBK's fundamentals are strong and it looks cheap: trading at 14x earnings, about half its usual 25x.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ECBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ECBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECBK.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ECBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $20.45 | — |
| Cheap | 18x | $26.66 | +30% |
| Fair | 25x | $37.12 | +82% |
| Expensive | 39x | $58.32 | +185% |
Historical ranges are pointers, not guarantees.
ECBK's PE is in its cheap range at 14x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ECBK Forward outlook
There aren't enough analyst estimates for ECBK to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ECBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.49 | +86% |
| Q2 2026 | $1.38 | +112% |
| Q1 2026 | $1.16 | +104% |
| Q4 2025 | $0.94 | +96% |
| Q3 2025 | $0.80 | +111% |
| Q2 2025 | $0.65 | +63% |
| Q1 2025 | $0.57 | +19% |
| Q4 2024 | $0.48 | -7.7% |
ECBK has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ECBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.1M | +26% |
| Q2 2026 | $10.3M | +29% |
| Q1 2026 | $10.2M | +47% |
| Q4 2025 | $9.5M | +34% |
| Q3 2025 | $8.8M | +33% |
| Q2 2025 | $8M | +27% |
| Q1 2025 | $6.9M | +11% |
| Q4 2024 | $7.1M | +15% |
ECBK's revenue has grown year over year for nine quarters in a row: $11M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +4.6 points |
| Q2 2026 | 43% | +19 points |
| Q1 2026 | 42% | +17 points |
| Q4 2025 | 37% | +9.4 points |
| Q3 2025 | 37% | +14 points |
| Q2 2025 | 24% | +7 points |
| Q1 2025 | 25% | +12 points |
| Q4 2024 | 27% | +10 points |
ECBK has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ECBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.4M | -13% |
| Q2 2026 | $11.8M | +538% |
| Q1 2026 | $2.8M | +$3.5M |
| Q4 2025 | $3.9M | -14% |
| Q3 2025 | $4M | +359% |
| Q2 2025 | $1.8M | +37% |
| Q1 2025 | -$649K | -$200K |
| Q4 2024 | $4.5M | +77% |
ECBK has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ECBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +56.5K shares |
| 1 year | +1.4% | +119K shares |
| 3 years | -1.1% | -93.4K shares |
ECBK has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $188,000 |
| Q2 2026 | $675,000 |
| Q1 2026 | $350,000 |
| Q4 2025 | $513,000 |
| Q3 2025 | $2M |
| Q2 2025 | $1.5M |
| Q1 2025 | $673,000 |
| Q4 2024 | $902,000 |
ECBK spent $2M buying back its own shares over the past year, down 65% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ECBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 16.3x | High |
| Q2 2026 | 17.9x | High |
| Q1 2026 | 19.5x | High |
| Q4 2025 | 26.3x | High |
| Q3 2025 | 28.1x | High |
| Q2 2025 | 34.9x | High |
| Q1 2025 | 35.0x | High |
| Q4 2024 | 40.2x | High |
ECBK's net debt is about 16 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ECBK.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ECBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 56.6 | Neutral |
ECBK's weekly RSI is 52 (neutral) and its Stochastic is 57 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ECBK PE vs Financial Services Sector
| Metric | ECBK | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 5.4% above |
| PE % | 0 | 58 | 58 pts below |
ECBK is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ECBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.9 | 1.9% below |
| 20 week MA | $20.7 | 1.1% below |
| 50 week MA | $18.9 | 8% above |
| 100 week MA | $17.3 | 18% above |
| 200 week MA | $15.2 | 35% above |
ECBK has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ECBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $14.0 | $16.1 | +15% |
| 2023 | $16.1 | $12.6 | -22% |
| 2024 | $12.6 | $14.9 | +19% |
| 2025 | $14.9 | $17.3 | +16% |
| 2026 YTD | $17.3 | $20.5 | +18% |
ECBK has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.